SVB Leerink analyst Marc Goodman maintains Evolus (NASDAQ:EOLS) with a Outperform and raises the price target from $18 to $20.
Where Comerica Stands With Analysts
Over the past 3 months, 10 analysts have published their opinion on Comerica (NYSE:CMA) stock. These analysts are…